Can This Leading Drug Developer Stock Live Up to the Hype?

Published by
The Street

By Maxx Chatsko The drug developer aims to build novel maps of biology. What the heck does that mean, exactly? Technology-enabled drug discovery promises to increase the efficiency of drug development. By combining artificial intelligence, robotic labs, and sometimes supercomputers, the emerging field thinks it can find better drug candidates faster. If those assets progress through clinical trials more easily, then it can shave years and tens or even hundreds of millions of dollars off traditional drug development cycles. Recursion Pharmaceuticals (RXRX) – Get Recursion Pharmaceuticals Inc. R…

Read More

See also  FORD AND ADT PARTNER UP TO BRING NEW THEFT DETERRENT TO PICKUP TRUCKS

Leave a Reply